The first question addressed to Dr. Soll focused on the trend for a difference in the survival of neonates receiving Curosurf/ Poractant Alfa (Curosurf s , DEY, LP, Napa, CA) vs Survanta/ Beractant (Survanta s , Abbott Laboratories, Abbott Park, IL) in the studies comparing these two animal-derived surfactant products. As the questioner stated, this trend appears to favor Curosurf s / Poractant Alfa (DEY, LP, Napa, CA) although since the doses used were different, it is possible that this difference could be doserelated rather than product-related.
In his answer to this question, Dr. Soll stated that Dr. Halliday and he were working on a paper for the Cochrane Reviews aimed at comparing the efficacy and side effects of different animal-driven surfactant products. He agreed that there might be consistent trends emerging. However, it is unclear whether the difference in reported survival is related to dosing or the product itself. He also noted that this review in progress could help in answering this question as many of the clinical studies included only a relatively small number of patients. Thus, the meta-analysis looking at all the available studies could help determining whether the differences were real.
The next question addressed to Dr. Saugstadt focused on the long-term neurodevelopmental outcome of neonates having been resuscitated with room air vs 100% oxygen. In his answer, Dr. Saugstadt stated that the only follow-up study he was aware of was his own study published in Pediatrics in 2003. This was a rather small follow-up study and they could not find any difference in neurodevelopmental outcome between the babies resuscitated in room air compared to those resuscitated in 100% oxygen. He suggested that, due to the relatively small number of patients involved, it would be premature to draw any conclusion regarding the effect on neurodevelopmental outcome of the gas (room air vs 100% oxygen) used for resuscitation.
The ensuing questions probed the two speakers about their opinion on the most appropriate levels of oxygen saturation in the very low birth weight neonate during the immediate postnatal period and later. Dr. Saugstadt stated that it would be premature to set exact guidelines and that these limits may be affected by both the patient's gestational and postnatal age and whether or not he/ she has developed chronic lung disease. However, the one statement he could make, he said, was that there were not any good data to make a final conclusion just yet.
Dr. Soll said that there was no pressing reason to think that a high saturation environment was beneficial. However, he said would not be able to define the lower limit of a safe oxygen saturation range for sure. He also stated that neonatologists should get out of the ''servo loop.'' In other words, stop twisting the dial and let the baby have some of the natural fluctuations.
Dr. Saugstadt was then asked whether he had looked at other components of room air F especially nitrogen F regarding the proposed protective effect. He replied that because of the role of nitrogen in maintaining lung volumes, it is conceivable that pure oxygen administration will result in more atelectasis simply by the absence of nitrogen from the gas mixture administered. He also added that, although his group did not have data from animal studies supporting a direct role of nitrogen in maintaining lung volumes and improving gas exchange, in the Resair-2 study there was a tendency for higher PaCO 2 values in the oxygen group compared to the patients who were resuscitated with room air. However, this was only a trend, which did not reach statistical significance.
Finally, Dr. Saugstadt was asked about the data in the literature linking oxygen administration to childhood cancer, especially leukemia. In his response, Dr. Saugstadt stated that there were indeed data from Sweden indicating that the only perinatal risk factor for childhood leukemia was exposure to oxygen immediately after birth. These epidemiological data suggest, he said, that a 3-to-10-minute oxygen exposure during resuscitation increases the risk for childhood leukemia more than three-fold. This was one of the reasons why his group was interested in looking at DNA damage caused by oxygen, he added. However, much more information is needed because these epidemiological data only found an association and not causation between delivery room exposure to oxygen and the potential for an increased incidence of childhood leukemia. 
